Concepedia

Author

David Slade

Research Triangle Park Foundation

Also Known As

D Slade, D. Slade, DAVID SLADE, David J. Slade, David Slade, Slade, D, Slade, David J.

57

Publications

231

Citations

10

H-Index

8

Concepts

All Affiliations

Research Triangle Park FoundationGlaxoSmithKline (United States)Rutgers, The State University of New JerseyRutgers New Jersey Medical SchoolAnalysis Group (United States)
DS

About

David Slade is an author at Research Triangle Park Foundation specializing in immunology, cancer research, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

11

2

Immunology

1

1

11

3

Hematology

1

1

11

4

Immunotherapy

1

1

11

5

Cancer Research

1

1

11

David Slade

×

9

Publications

155

Citations

9

H-Index

YearCitations

Role of Matrix Metalloproteinases-1 and -2 in Interleukin-13–Suppressed Elastin in Airway Fibroblasts in Asthma

Jennifer L. Ingram, David Slade, Tony D. Church,

American Journal of Respiratory Cell and Molecular Biology

2015

27

Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma

John Oppenheimer, Nicola A. Hanania, Rekha Chaudhuri,

CHEST Journal

2023

26

Real-world evidence

John Oppenheimer, David Slade, Beth Hahn,

Annals of Allergy Asthma & Immunology

2020

23

Disease burden and treatment adherence among children and adolescent patients with asthma

Carlyne M. Averell, François Laliberté, Guillaume Germain,

Journal of Asthma

2021

17

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States

Carlyne M. Averell, François Laliberté, Guillaume Germain,

Therapeutic Advances in Respiratory Disease

2022

16

Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes

Shiyuan Zhang, John White, Alyssa Goolsby Hunter,

npj Primary Care Respiratory Medicine

2023

13

A Livetrapping Technique for River Otters

Tom H. Northcott, David Slade

Journal of Wildlife Management

1976

12

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT

Andrew J. Innes, R Mark Beattie, Ruhena Sergeant,

Bone Marrow Transplantation

2013

11

Is Asthma Clinical Remission Achievable by Inhaled Therapy? A Post-Hoc Analysis of Single Inhaler Triple Therapy with FF/UMEC/VI in the CAPTAIN Trial

Njira Lugogo, John Oppenheimer, Jodie Crawford,

Journal of Allergy and Clinical Immunology

2024

10

Page 1